You are here:
Home
:
PCU 2 | 2006
:
PCU 2 | 2006 Audio
Go to Case Discussions
Go to interview with Judd W Moul, MD
Go to interview with Daniel P Petrylak, MD
To listen to individual tracks, click the on the track you wish to listen to.
To download tracks, right-click on the one you wish to download.
Case Discussions
Click here to download the entire segment
Track 1
Introduction
Track 2
Case discussion: A 62-year-old man with Stage T1c, Gleason 7 prostate cancer
Track 3
Management of focal positive margins
Track 4
Radiation therapy after prostatectomy for patients with positive margins
Track 5
Case discussion: A 53-year-old man with Gleason 9 prostate cancer and extracapsular extension
Track 6
High-volume versus low-volume Gleason 9 disease
Track 7
Hormonal therapy after radical prostatectomy for high-risk prostate cancer
Track 8
Trials of chemotherapy in the adjuvant setting
Track 9
Combined androgen blockade as adjuvant therapy after radical prostatectomy
Track 10
Role of postoperative radiation therapy after radical prostatectomy
Track 11
Incidence of sexual dysfunction with postoperative radiation therapy
Track 12
PSA threshold for initiating hormonal therapy
Track 13
Case discussion: A 50-year-old man with PSA at 0.2 ng/mL and small volume disease
Track 14
Rationale for biopsy of patients with a low PSA level
Track 15
Watchful waiting for patients with a small volume disease
Track 16
Incidence and challenges of nonsignificant prostate cancer
Track 17
Watchful waiting for patients with low-risk disease
Track 18
Role of dietary modification and vitamins for patients on watchful waiting
Track 19
Case discussion: An 84-year-old man with hormone-refractory metastatic prostate cancer
Track 20
Symptom improvement associated with docetaxel
Track 21
Side effects of docetaxel
Track 22
Future directions in immune therapy of prostate cancer
Track 23
Benefit of input from medical oncologists in management of prostate cancer
Track 24
Case discussion: A 71-year-old man with high-risk prostate cancer
Track 25
Treatment options for patients with high-risk disease
Track 26
Difference in quality of life on androgen deprivation therapy and bicalutamide monotherapy
Track 27
Side effects of androgen deprivation therapy
Track 28
Clinical use of bicalutamide monotherapy
Track 29
Adverse effects associated with bicalutamide monotherapy
Track 30
Clinical use of therapies without definitive clinical trial data
Track 31
Cardiovascular morbidity in patients receiving androgen deprivation therapy
Track 32
Use of PSA and PSA doubling time to determine treatment approach
Track 33
Challenges of accruing patients to clinical trials in prostate cancer
Track 34
Tolerability of single-agent docetaxel
Judd W Moul, MD
Professor and Chief
Division of Urologic Surgery
Duke University Medical Center
Durham, North Carolina
Click here to download the entire segment
Track 1
Introduction
Track 2
Use of PSA velocity in screening for prostate cancer
Track 3
Potential role of biomarkers in the diagnosis of prostate cancer
Track 4
Disease management for patients with PSA-only progression
Track 5
Robotic versus open prostatectomy
Track 6
Importance of experience in the quality of robotic prostatectomies
Track 7
Efficacy and tolerability of docetaxel
Track 8
Potential role of chemotherapy in the treatment of PSA-only, hormone-refractory disease
Track 9
Case discussion: A 42-year-old man treated with preoperative docetaxel and hormonal therapy
Track 10
Cryotherapy and high-intensity focused ultrasound
Track 11
Viral etiology associated with prostate cancer
Track 12
Current controversies in the management of prostate cancer
Daniel P Petrylak, MD
Associate Professor of Medicine
Director, Genitourinary Oncology Program
Columbia Presbyterian Medical Center
New York, New York
Click here to download the entire segment
Track 1
Introduction
Track 2
Case discussion: A 46-year-old man with PSA-only, hormone-refractory disease
Track 3
Chemotherapy for PSA-only disease
Track 4
Clinical use of intermittent androgen therapy
Terms of Use and General Disclaimer
Copyright © Research To Practice, 2006. All Rights Reserved.
